Form D — Evommune, Inc.
0002044725-25-000003 · filed Jan 8, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other filings
Offering
- Industry
- Other
- Exemptions
- 06b
- Reported offering amount
- $57,500,000
- Reported amount sold
- $57,500,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Evommune, Inc.
- CIK
- 2044725
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 1841 PAGE MILL RD
PALO ALTO, CA 94304 - Phone
- (650) 223-7745
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Luis Pena · Executive OfficerPalo Alto, CA Find on LinkedIn ↗
-
Eugene Bauer · Executive OfficerPalo Alto, CA Find on LinkedIn ↗
-
Robert Hopfner · DirectorPalo Alto, CA Find on LinkedIn ↗
-
Yuexin Yu · DirectorPalo Alto, CA Find on LinkedIn ↗
-
Felice Verduyn-van Weegen · DirectorPalo Alto, CA Find on LinkedIn ↗
-
Derek DiRocco · DirectorPalo Alto, CA Find on LinkedIn ↗
-
Francois Beaubien · DirectorPalo Alto, CA Find on LinkedIn ↗
-
Benjamin McGraw · DirectorPalo Alto, CA Find on LinkedIn ↗
-
David Cohen · DirectorPalo Alto, CA Find on LinkedIn ↗
-
Kyle Carver · Executive OfficerPalo Alto, CA Find on LinkedIn ↗
-
Gregory Moss · Executive OfficerPalo Alto, CA Find on LinkedIn ↗
-
Jeegar Patel · Executive OfficerPalo Alto, CA Find on LinkedIn ↗
-
Janice Drew · Executive OfficerPalo Alto, CA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗